U.S. Tech Hardware Stock News

NYSE:DBRG
NYSE:DBRGCapital Markets

Reassessing DigitalBridge Group (DBRG) After Its 44% One-Year Share Price Surge

If you are wondering whether DigitalBridge Group is still attractively priced after its recent run, looking closely at its valuation metrics can help you decide what the current share price really offers. The stock last closed at US$15.41, with returns of 0.0% over 7 days, 0.4% over 30 days, 0.2% year to date, 43.9% over 1 year, 13.5% over 3 years, and a 36.3% decline over 5 years. Taken together, these figures give a mixed picture of how the market has treated the shares over different...
NYSE:FE
NYSE:FEElectric Utilities

FirstEnergy (FE) Margin Improvement To 9.3% TTM Tests Bearish Profitability Narrative

FirstEnergy FY 2025 Earnings Snapshot FirstEnergy (FE) just posted its latest FY 2025 numbers with Q3 revenue of US$4.1 billion and basic EPS of US$0.76, setting a clear marker for how the year is shaping up. The company has seen revenue move from US$3.0 billion in Q4 2024 to US$3.4 billion in Q2 2025 and US$4.1 billion in Q3 2025, while quarterly EPS ranged from US$0.45 to US$0.76 over the same stretch, and trailing twelve month EPS sits at US$2.31 on revenue of US$14.3 billion. With net...
NasdaqGS:PERI
NasdaqGS:PERIMedia

Perion Network Q3 Loss Reinforces Bearish Narrative Around Earnings Deterioration

Perion Network (PERI) just posted its FY 2025 third quarter numbers, reporting revenue of US$110.5 million and a loss per share of US$0.10 based on basic EPS, as net income excluding extra items came in at a US$4.1 million loss. The company’s quarterly revenue moved from US$108.7 million in Q2 2024 to US$102.2 million in Q3 2024 and then to US$110.5 million in Q3 2025. Over the same periods, basic EPS shifted from a loss of US$0.13 in Q2 2024 to EPS of US$0.05 in Q3 2024 and then a loss of...
NasdaqGM:TCMD
NasdaqGM:TCMDMedical Equipment

Tactile Systems Technology (TCMD) EPS Turnaround Challenges Slower Growth Narrative

Tactile Systems Technology (TCMD) has wrapped up FY 2025 with fourth quarter revenue of US$103.6 million and basic EPS of US$0.47, alongside trailing 12 month revenue of US$329.5 million and EPS of US$0.83 that frame the full year picture. The company has seen quarterly revenue move from US$61.3 million in Q1 2025 to US$103.6 million in Q4 2025, while basic EPS shifted from a loss of US$0.13 in Q1 to a profit of US$0.47 in Q4, setting up a results season where investors are likely to focus on...
NYSE:JELD
NYSE:JELDBuilding

JELD WEN Holding (JELD) Deep FY 2025 Loss Tests Bullish Turnaround Narratives

JELD-WEN Holding (JELD) has just posted a tough FY 2025 finish, with fourth quarter revenue of US$802 million and a basic EPS loss of US$0.47, alongside trailing 12 month revenue of about US$3.2 billion and a full year basic EPS loss of US$7.27. The company has seen quarterly revenue move from US$895.7 million in Q4 2024 to US$802 million in Q4 2025, while basic EPS shifted from a loss of US$0.81 to a loss of US$0.47 over the same period. This leaves investors to consider whether pressure on...
NasdaqGS:GLBE
NasdaqGS:GLBEMultiline Retail

Global E Online (GLBE) Earnings Turn Positive EPS Story Tests High Growth Narratives

Global‑E Online (GLBE) has just posted its FY 2025 third quarter numbers, with revenue of US$220.8 million and basic EPS of US$0.08 on net income of US$13.2 million. This gives investors fresh data on how the cross border e commerce platform is converting top line scale into bottom line results. The company has seen quarterly revenue move from US$168.0 million in Q2 2024 to US$175.9 million in Q3 2024, then to US$189.9 million in Q1 2025, US$214.9 million in Q2 2025 and US$220.8 million in...
NYSE:LPX
NYSE:LPXForestry

Louisiana-Pacific Dividend Hike Leans On Siding Strength And Cash Flows

Louisiana-Pacific (NYSE:LPX) announced a 7% dividend increase, signaling confidence in its financial position. The company recently highlighted strong growth in its Siding business and operational improvements. These updates come as the housing market remains challenging, with demand under pressure. For you as an investor, the key point is that NYSE:LPX is leaning on its Siding segment and efficiency gains while housing conditions stay tough. The company focuses on building products, so...
NasdaqGS:MASI
NasdaqGS:MASIMedical Equipment

Masimo Shareholders Weigh Danaher Cash Offer And Rich Valuation Risk

Danaher Corporation has agreed to acquire Masimo (NasdaqGS:MASI) in a definitive all cash transaction. The deal terms value Masimo entirely in cash, with closing subject to customary approvals and conditions. A legal investigation has been launched to assess whether the acquisition terms are fair to Masimo shareholders. Masimo, known for patient monitoring and related medical technology, sits at the intersection of healthcare equipment and digital health tools. The proposed acquisition by...
NYSE:TRAK
NYSE:TRAKSoftware

ReposiTrak (TRAK) Margins Hold Near 30% And Support Existing Bullish Efficiency Narratives

ReposiTrak (TRAK) has put up another steady quarter in Q2 2026, reporting revenue of US$5.9 million and basic EPS of US$0.09, with net income excluding extra items at US$1.6 million as investors weigh these figures against its recent growth track record. The company has seen quarterly revenue move from US$5.5 million in Q2 2025 to US$5.9 million in the latest quarter, while basic EPS over that span has ranged between US$0.08 and US$0.10. This is setting the stage for investors to focus on how...
NYSE:COUR
NYSE:COURConsumer Services

Coursera Udemy Combination Puts AI Growth Vision And Valuation In Focus

Coursera, NYSE:COUR, has announced an agreement to combine with Udemy. The companies plan to create a larger online learning platform with a focus on AI powered experiences. The move signals consolidation in online education and is expected to be closely watched by investors and industry participants. For investors tracking NYSE:COUR, the announcement comes after a challenging period for the share price. Coursera closed at $5.93, with a 3.3% gain over the past week but declines of 5.7% over...
NasdaqGS:ILMN
NasdaqGS:ILMNLife Sciences

Is Illumina (ILMN) Pricing Look Attractive After Mixed Long Term Share Performance

If you are wondering whether Illumina's current share price lines up with its underlying worth, this article will walk you through what the numbers are really saying about value. The stock closed at US$120.09, with returns of 3.2% over the last 7 days, a 15.2% decline over 30 days, a 10.6% decline year to date, a 16.6% gain over 1 year, a 38.7% decline over 3 years and a 73.2% decline over 5 years. The pricing story has therefore been quite mixed across different time frames. Recent news...
NYSE:MFA
NYSE:MFAMortgage REITs

MFA Financial (MFA) Dividend Coverage Concerns Reinforce Bearish Narratives After Q3 FY 2025 Results

MFA Financial (MFA) has put up steady quarterly numbers in FY 2025 so far, with Q3 revenue of US$85 million and EPS of US$0.36, alongside net income of US$37 million. The company has seen revenue move between US$72 million and US$90 million per quarter over the past six reported periods, with EPS ranging from a small loss of US$0.02 to US$0.38. This gives investors a clearer view of how the income line and per share results have tracked through recent conditions. With trailing 12 month net...
NYSE:SPH
NYSE:SPHGas Utilities

Assessing Suburban Propane Partners (SPH) Valuation After First Quarter Earnings Jump

Suburban Propane Partners (SPH) caught investor attention after reporting first quarter 2025 earnings, with net income of US$45.78 million compared to US$19.42 million a year earlier, on relatively stable revenue of about US$370 million. See our latest analysis for Suburban Propane Partners. The latest earnings release appears to sit alongside gradually improving sentiment, with a 30 day share price return of 5.52% and a 90 day gain of 8.35%. The 5 year total shareholder return of 96.45%...
NasdaqGS:WING
NasdaqGS:WINGHospitality

Wingstop (WING) Margin Surge To 25.5% Reinforces Bullish Profitability Narrative

Wingstop (WING) just posted its FY 2025 third quarter numbers, reporting revenue of US$175.7 million and basic EPS of US$1.02, while trailing twelve month EPS is US$6.15 on revenue of US$683.0 million. The company’s revenue has moved from US$162.5 million and EPS of US$0.88 in Q3 2024 to US$175.7 million and EPS of US$1.02 in Q3 2025. This sits alongside trailing net income of US$174.3 million, which contributes to the 25.5% net margin reported over the past year and highlights a results...
NasdaqGS:ADI
NasdaqGS:ADISemiconductor

Analog Devices (ADI) Net Margin Expansion Tests Bullish Long‑Term Profitability Narratives

Analog Devices (ADI) opened its new fiscal year with Q1 2026 results that sit on top of a clear ramp in recent quarters, with revenue moving from US$2,443.2 million in Q4 2024 to US$3,076.1 million in Q4 2025 and basic EPS stepping up from US$0.96 to US$1.60 over the same period. Over the trailing twelve months to Q4 2025, total revenue reached US$11.0 billion and basic EPS came in at US$4.59. This gives investors a fuller sense of earnings power coming into this latest print and sets the...
NasdaqGS:ROIV
NasdaqGS:ROIVBiotechs

A Look At Roivant Sciences (ROIV) Valuation After PHocus Trial Milestone And Weak Quarterly Earnings

Clinical and earnings updates shift focus for Roivant Sciences (ROIV) Roivant Sciences (ROIV) shares are in focus after the company reported a key clinical milestone for its pulmonary hypertension program and quarterly results that showed lower sales and a larger net loss compared with last year. See our latest analysis for Roivant Sciences. The clinical milestone and latest earnings are landing against a backdrop of strong momentum, with Roivant Sciences showing a 30 day share price return...
NYSE:BLCO
NYSE:BLCOMedical Equipment

Bausch + Lomb (BLCO) Loss Narrows To US$28m As Margin Repair Narrative Gains Traction

Bausch + Lomb (NYSE:BLCO) has put out its latest FY 2025 numbers with Q3 revenue of US$1.3b and a basic EPS loss of US$0.08, as investors weigh how far the business has come toward closing the profitability gap. The company has seen quarterly revenue move from US$1.1b in Q1 2025 to US$1.3b in Q3, while basic EPS losses over that stretch ranged from US$0.60 in Q1 to US$0.18 in Q2 and US$0.08 in Q3. This sets up the current update as a check-in on how quickly margins can repair from here. See...
NYSE:RBA
NYSE:RBACommercial Services

RB Global (RBA) Margin Slippage Tests Bullish Multi Year Earnings Growth Narrative

RB Global (RBA) has wrapped up FY 2025 with fourth quarter revenue of US$1.2 billion and basic EPS of US$0.53, alongside net income excluding extra items of US$99.1 million. This sets a clear marker for how the year finished. Across recent periods, the company has seen quarterly revenue range from US$981.8 million in Q3 2024 to US$1.2 billion in Q4 2025, while basic EPS moved between US$0.36 and US$0.56 over that span. This gives investors a concrete view of how the top and bottom lines have...
NasdaqGM:TMDX
NasdaqGM:TMDXMedical Equipment

FDA Greenlights ENHANCE Heart Trial As TransMedics Valuation Draws Attention

TransMedics Group received full FDA approval for its Next-Generation OCS ENHANCE Heart trial Investigational Device Exemption. The trial is designed to assess the company’s Organ Care System Heart technology for prolonged heart perfusion versus current storage methods. This FDA decision marks a material development for NasdaqGM:TMDX and its organ transplant platform. TransMedics Group, trading on NasdaqGM:TMDX, now has a fresh regulatory green light that adds to its profile in the heart...
NasdaqGS:KRYS
NasdaqGS:KRYSBiotechs

Is Krystal Biotech (KRYS) Priced Right After A 61% One-Year Share Gain?

If you are wondering whether Krystal Biotech's share price reflects its true worth, this article will walk through how the current market price compares with a range of valuation checks. The stock last closed at US$283.29, with returns of 3.9% over 7 days, 14.7% year to date, and 60.8% over the past year. This performance has put it firmly on many investors' radar. Recent interest in Krystal Biotech has been shaped by ongoing attention to its gene therapy pipeline and regulatory milestones...
NYSE:SMWB
NYSE:SMWBSoftware

Similarweb (SMWB) Q4 Loss Widens As Profitability Timeline Faces Bullish Narrative Test

Similarweb (SMWB) has wrapped up FY 2025 with Q4 revenue of US$72.8 million and a basic EPS loss of US$0.09, alongside net income excluding extra items of a US$7.5 million loss. The company has seen revenue move from US$65.6 million in Q4 2024 to US$72.8 million in Q4 2025, while quarterly basic EPS shifted from a US$0.07 loss to a US$0.09 loss over the same period. This sets up a story focused on how quickly margins can tighten or ease from here. See our full analysis for Similarweb. With...
NYSE:MCO
NYSE:MCOCapital Markets

Moody's (MCO) Margin Strength Reinforces Bullish Narratives Despite Premium Valuation Concerns

Moody's (MCO) has just posted third quarter FY 2025 revenue of US$2.0b and basic EPS of US$3.61, with trailing twelve month revenue at US$7.5b and EPS at US$12.48 framing the latest print within a larger earnings run rate. The company has seen quarterly revenue move from US$1.82b in Q2 2024 to US$1.90b in Q2 2025 and then US$2.01b in Q3 2025, while basic EPS moved from US$3.03 to US$3.22 and then US$3.61 over the same quarters, giving investors a clear view of how the income statement is...
NasdaqGS:GSHD
NasdaqGS:GSHDInsurance

Goosehead Insurance (GSHD) Margin Compression Challenges Bullish Earnings Growth Narratives

Goosehead Insurance (GSHD) closed FY 2025 with fourth quarter revenue of US$105.3 million and basic EPS of US$0.50, alongside trailing twelve month revenue of US$365.3 million and EPS of US$1.11 that frame the latest print in a wider context of reported earnings. Over the past six quarters, revenue has moved from US$77.8 million in Q3 2024 to US$105.3 million in Q4 2025, while quarterly EPS has ranged from US$0.09 in Q1 2025 to US$0.60 in Q4 2024. This gives investors a clearer view of how...